# Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection

> **NCT01082718** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Centers for Disease Control and Prevention**

## Conditions studied

- Malaria
- Pregnancy

## Interventions

- **DRUG:** Mefloquine Artesunate

## Key facts

- **NCT ID:** NCT01082718
- **Lead sponsor:** Centers for Disease Control and Prevention
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Logistical difficulties
- **Last updated:** 2012-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01082718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01082718, "Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01082718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*